Total Funding
84
40
Total FundingVenture - Series Unknown raised
Growth Score 84 in past quarter
-3 pts
Heat Score 40 in past quarter
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
988649
MuciMed engages in the development of mucin proteins for the treatment of gastrointestinal disease.
Donald Parfet: DirectorPast Role: Pharmacia, Senior Vice President
About the Company
MuciMed, Inc. engages in developing and commercializing mucin proteins for the treatment of gastrointestinal disease. The company was incorporated in 2005 and is based in Kalamazo, Michigan.